HEADER HYDROLASE/HYDROLASE INHIBITOR 15-JAN-07 2JE4 TITLE ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 TITLE 2 PROTEASE IN COMPLEX WITH JG-365 CAVEAT 2JE4 JG3 C 4 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HIV1-PROTEASE; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: INHIBITOR MOLECULE JG365; COMPND 7 CHAIN: C; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 MOL_ID: 2; SOURCE 5 SYNTHETIC: YES; SOURCE 6 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 7 ORGANISM_TAXID: 32630 KEYWDS PROTEASE, HYDROLASE, HIGH RESOLUTION, ASPARTYL PROTEASE, HUMAN KEYWDS 2 IMMUNODEFICIENCY VIRUS 1, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION NUMMDL 2 AUTHOR E.MALITO,E.C.B.JOHNSON,W.J.TANG REVDAT 12 13-DEC-23 2JE4 1 REMARK REVDAT 11 15-NOV-23 2JE4 1 REMARK ATOM REVDAT 10 16-OCT-19 2JE4 1 REMARK REVDAT 9 22-MAY-19 2JE4 1 REMARK LINK REVDAT 8 18-OCT-17 2JE4 1 CAVEAT REMARK REVDAT 7 08-FEB-17 2JE4 1 SOURCE REMARK REVDAT 6 10-DEC-14 2JE4 1 REMARK REVDAT 5 20-JUL-11 2JE4 1 SOURCE REVDAT JRNL REMARK REVDAT 5 2 1 MASTER REVDAT 4 13-JUL-11 2JE4 1 VERSN REVDAT 3 24-FEB-09 2JE4 1 VERSN REVDAT 2 25-SEP-07 2JE4 1 JRNL REVDAT 1 28-AUG-07 2JE4 0 JRNL AUTH E.C.B.JOHNSON,E.MALITO,Y.SHEN,D.RICH,W.J.TANG,S.B.KENT JRNL TITL MODULAR TOTAL CHEMICAL SYNTHESIS OF A HUMAN IMMUNODEFICIENCY JRNL TITL 2 VIRUS TYPE 1 PROTEASE. JRNL REF J.AM.CHEM.SOC. V. 129 11480 2007 JRNL REFN ISSN 0002-7863 JRNL PMID 17705484 JRNL DOI 10.1021/JA072870N REMARK 2 REMARK 2 RESOLUTION. 1.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.144 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.143 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.184 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3830 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 75585 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.132 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.143 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.184 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 3044 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 61019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1567 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 59 REMARK 3 SOLVENT ATOMS : 394 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1791.9 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1379.9 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 44 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 18150 REMARK 3 NUMBER OF RESTRAINTS : 24635 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.016 REMARK 3 ANGLE DISTANCES (A) : 0.039 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.035 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.106 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.087 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.043 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.007 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.061 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.098 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2JE4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1290031097. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL; NULL REMARK 200 TEMPERATURE (KELVIN) : 150; NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : APS; APS REMARK 200 BEAMLINE : 14-BM-C; 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987; 0.987 REMARK 200 MONOCHROMATOR : NULL; NULL REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL; NULL REMARK 200 DETECTOR MANUFACTURER : NULL; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 72978 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.070 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 28.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.07 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.33200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 7HVP REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: WELL SOLUTION 0.1 M CITRATE, 0.2 M REMARK 280 SODIUM PHOSPHATE, 30% SATURATED AMMONIUM SULFATE, AND 10% DMSO, REMARK 280 PH 6.0, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.25050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.44300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.42650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.44300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.25050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.42650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -73.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE JG-365 IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: JG-365 REMARK 400 CHAIN: C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 1 ACE C 0 REMARK 465 2 ACE C 0 REMARK 465 2 SER C 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 1 LYS A 41 CG CD CE NZ REMARK 470 1 CYS A 95 SG REMARK 470 1 CYS B 95 SG REMARK 470 1 VME C 6 OXT REMARK 470 2 LYS A 41 CG CD CE NZ REMARK 470 2 CYS A 95 SG REMARK 470 2 CYS B 95 SG REMARK 470 2 VME C 6 OXT REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 1 PHE A 99 C PHE A 99 OXT 0.141 REMARK 500 1 PHE A 99 C PHE A 99 OXT 0.186 REMARK 500 1 PHE B 99 C PHE B 99 OXT 0.135 REMARK 500 1 SER C 1 N SER C 1 CA 0.157 REMARK 500 1 SER C 1 CA SER C 1 CB 0.230 REMARK 500 2 PHE A 99 C PHE A 99 OXT 0.141 REMARK 500 2 PHE A 99 C PHE A 99 OXT 0.186 REMARK 500 2 PHE B 99 C PHE B 99 OXT 0.135 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 1 ARG A 8 NE - CZ - NH1 ANGL. DEV. = -4.9 DEGREES REMARK 500 1 ARG A 14 NE - CZ - NH1 ANGL. DEV. = -4.2 DEGREES REMARK 500 1 ARG A 14 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 1 ILE A 50 CB - CA - C ANGL. DEV. = -12.4 DEGREES REMARK 500 1 ILE A 50 CA - CB - CG1 ANGL. DEV. = -18.5 DEGREES REMARK 500 1 PHE A 53 CB - CG - CD2 ANGL. DEV. = -5.3 DEGREES REMARK 500 1 ARG A 57 NE - CZ - NH1 ANGL. DEV. = -4.2 DEGREES REMARK 500 1 ARG B 14 CD - NE - CZ ANGL. DEV. = 16.5 DEGREES REMARK 500 1 ARG B 14 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 1 ARG B 57 NE - CZ - NH1 ANGL. DEV. = -3.9 DEGREES REMARK 500 2 ARG A 8 NE - CZ - NH1 ANGL. DEV. = -4.9 DEGREES REMARK 500 2 ARG A 14 NE - CZ - NH1 ANGL. DEV. = -4.2 DEGREES REMARK 500 2 ARG A 14 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 2 ILE A 50 CB - CA - C ANGL. DEV. = -12.4 DEGREES REMARK 500 2 ILE A 50 CA - CB - CG1 ANGL. DEV. = -18.5 DEGREES REMARK 500 2 PHE A 53 CB - CG - CD2 ANGL. DEV. = -5.3 DEGREES REMARK 500 2 ARG A 57 NE - CZ - NH1 ANGL. DEV. = -4.2 DEGREES REMARK 500 2 ARG B 14 CD - NE - CZ ANGL. DEV. = 16.5 DEGREES REMARK 500 2 ARG B 14 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 2 ARG B 57 NE - CZ - NH1 ANGL. DEV. = -3.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 JG3 C 4 ILE C 5 1 -109.02 REMARK 500 JG3 C 4 ILE C 5 2 -111.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 1 JG3 C 4 30.74 REMARK 500 2 JG3 C 4 33.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2027 DISTANCE = 11.77 ANGSTROMS REMARK 525 HOH A2045 DISTANCE = 6.12 ANGSTROMS REMARK 525 HOH A2046 DISTANCE = 6.12 ANGSTROMS REMARK 525 HOH A2063 DISTANCE = 9.11 ANGSTROMS REMARK 525 HOH A2160 DISTANCE = 5.88 ANGSTROMS REMARK 525 HOH A2161 DISTANCE = 6.09 ANGSTROMS REMARK 525 HOH A2162 DISTANCE = 6.09 ANGSTROMS REMARK 525 HOH A2164 DISTANCE = 5.88 ANGSTROMS REMARK 525 HOH B2054 DISTANCE = 5.90 ANGSTROMS REMARK 525 HOH A2027 DISTANCE = 11.59 ANGSTROMS REMARK 525 HOH A2063 DISTANCE = 8.37 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 7-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 8-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "BA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 7-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 8-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1100 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1105 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1109 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1112 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 1100 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1103 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF INHIBITOR MOLECULE REMARK 800 JG365 DBREF 2JE4 A 1 99 UNP O38716 O38716_9HIV1 1 99 DBREF 2JE4 B 1 99 UNP O38716 O38716_9HIV1 1 99 DBREF 2JE4 C 0 6 PDB 2JE4 2JE4 0 6 SEQADV 2JE4 LYS A 7 UNP O38716 GLN 7 CONFLICT SEQADV 2JE4 ILE A 33 UNP O38716 LEU 33 CONFLICT SEQADV 2JE4 LYS B 7 UNP O38716 GLN 7 CONFLICT SEQADV 2JE4 ILE B 33 UNP O38716 LEU 33 CONFLICT SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU NLE ASN LEU PRO SEQRES 4 A 99 GLY LYS TRP LYS PRO LYS NLE ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU SEQRES 6 A 99 ILE DBU GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU NLE ASN LEU PRO SEQRES 4 B 99 GLY LYS TRP LYS PRO LYS NLE ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU SEQRES 6 B 99 ILE DBU GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 C 7 ACE SER LEU ASN JG3 ILE VME MODRES 2JE4 NLE A 36 LEU NORLEUCINE MODRES 2JE4 NLE A 46 LEU NORLEUCINE MODRES 2JE4 DBU A 67 THR (2Z)-2-AMINOBUT-2-ENOIC ACID MODRES 2JE4 NLE B 36 LEU NORLEUCINE MODRES 2JE4 NLE B 46 LEU NORLEUCINE MODRES 2JE4 DBU B 67 THR (2Z)-2-AMINOBUT-2-ENOIC ACID HET NLE A 36 8 HET NLE A 46 8 HET DBU A 67 6 HET NLE B 36 8 HET NLE B 46 8 HET DBU B 67 6 HET JG3 C 4 19 HET VME C 6 9 HET ACT A1100 4 HET ACT A1101 4 HET GOL A1102 6 HET GOL A1103 6 HET GOL A1104 6 HET SO4 A1105 5 HET SO4 A1109 5 HET SO4 A1112 5 HET ACT B1100 4 HET ACT B1101 4 HET SO4 B1102 5 HET SO4 B1103 5 HETNAM NLE NORLEUCINE HETNAM DBU (2Z)-2-AMINOBUT-2-ENOIC ACID HETNAM JG3 1-[(2S,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-L-PROLINE HETNAM VME METHYL L-VALINATE HETNAM ACT ACETATE ION HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETSYN DBU Z-DEHYDROBUTYRINE HETSYN VME O-METHYLVALINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 NLE 4(C6 H13 N O2) FORMUL 1 DBU 2(C4 H7 N O2) FORMUL 3 JG3 C15 H22 N2 O3 FORMUL 3 VME C6 H13 N O2 FORMUL 4 ACT 4(C2 H3 O2 1-) FORMUL 6 GOL 3(C3 H8 O3) FORMUL 9 SO4 5(O4 S 2-) FORMUL 16 HOH *394(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLY B 86 THR B 91 1 6 HELIX 3 3 GLN B 92 GLY B 94 5 3 SHEET 1 AA 4 GLN A 2 ILE A 3 0 SHEET 2 AA 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 AA 4 THR A 96 ASN A 98 -1 O THR A 96 N ASN B 98 SHEET 4 AA 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 AB 8 LEU A 10 ILE A 15 0 SHEET 2 AB 8 GLN A 18 LEU A 24 -1 O GLN A 18 N ILE A 15 SHEET 3 AB 8 ILE A 84 ILE A 85 1 N ILE A 85 O LEU A 23 SHEET 4 AB 8 VAL A 32 ILE A 33 -1 O VAL A 32 N ILE A 84 SHEET 5 AB 8 LYS A 70 VAL A 77 1 O LEU A 76 N ILE A 33 SHEET 6 AB 8 GLY A 52 GLU A 65 -1 O ARG A 57 N VAL A 77 SHEET 7 AB 8 LEU A 10 ILE A 15 -1 O ARG A 14 N GLU A 65 SHEET 8 AB 8 LEU A 10 ILE A 15 0 SHEET 1 BA 8 LEU B 10 ILE B 15 0 SHEET 2 BA 8 GLN B 18 LEU B 24 -1 O GLN B 18 N ILE B 15 SHEET 3 BA 8 ILE B 84 ILE B 85 1 N ILE B 85 O LEU B 23 SHEET 4 BA 8 VAL B 32 ILE B 33 -1 O VAL B 32 N ILE B 84 SHEET 5 BA 8 LYS B 70 VAL B 77 1 O LEU B 76 N ILE B 33 SHEET 6 BA 8 GLY B 52 GLU B 65 -1 O ARG B 57 N VAL B 77 SHEET 7 BA 8 LEU B 10 ILE B 15 -1 O ARG B 14 N GLU B 65 SHEET 8 BA 8 LEU B 10 ILE B 15 0 LINK C AGLU A 35 N ANLE A 36 1555 1555 1.35 LINK C ANLE A 36 N AASN A 37 1555 1555 1.32 LINK C ALYS A 45 N ANLE A 46 1555 1555 1.32 LINK C ANLE A 46 N AILE A 47 1555 1555 1.32 LINK C AILE A 66 N ADBU A 67 1555 1555 1.34 LINK C ADBU A 67 N AGLY A 68 1555 1555 1.32 LINK C AGLU B 35 N ANLE B 36 1555 1555 1.31 LINK C ANLE B 36 N AASN B 37 1555 1555 1.36 LINK C ALYS B 45 N ANLE B 46 1555 1555 1.34 LINK C ANLE B 46 N AILE B 47 1555 1555 1.30 LINK C AILE B 66 N ADBU B 67 1555 1555 1.34 LINK C ADBU B 67 N AGLY B 68 1555 1555 1.33 LINK C AASN C 3 N AJG3 C 4 1555 1555 1.33 LINK C AJG3 C 4 N AILE C 5 1555 1555 1.34 SITE 1 AC1 4 TRP A 42 PRO A 44 GLU A 65 GLY A 68 SITE 1 AC2 5 GLU A 21 VAL A 82 ASN A 83 HOH A2059 SITE 2 AC2 5 HOH A2061 SITE 1 AC3 10 PHE A 99 HOH A2201 HOH A2202 HOH A2203 SITE 2 AC3 10 HOH A2204 PHE B 53 LYS B 55 HIS B 69 SITE 3 AC3 10 ACT B1100 SO4 B1103 SITE 1 AC4 5 THR A 12 LYS A 41 TRP A 42 HOH A2032 SITE 2 AC4 5 HOH A2033 SITE 1 AC5 12 GLN A 2 HOH A2205 HOH A2206 HOH A2207 SITE 2 AC5 12 HOH A2208 HOH A2209 HOH A2210 HOH A2211 SITE 3 AC5 12 HOH A2212 PRO B 44 VAL B 56 ARG B 57 SITE 1 AC6 7 PRO A 1 ASN A 37 ARG A 57 HIS A 69 SITE 2 AC6 7 SO4 A1109 HOH A2213 HOH A2214 SITE 1 AC7 4 PRO A 1 HIS A 69 SO4 A1105 PHE B 99 SITE 1 AC8 10 HOH A2039 HOH A2080 HOH A2122 HOH A2215 SITE 2 AC8 10 ARG B 14 ILE B 15 GLY B 16 GLY B 17 SITE 3 AC8 10 PRO B 63 SO4 B1102 SITE 1 AC9 6 LYS A 70 GOL A1102 LYS B 55 SO4 B1103 SITE 2 AC9 6 HOH B2170 HOH B2171 SITE 1 BC1 4 LYS A 55 LYS A 70 ARG B 14 LYS B 70 SITE 1 BC2 11 ARG A 14 GLY A 17 SO4 A1112 HOH A2040 SITE 2 BC2 11 HOH A2042 HOH A2080 HOH A2215 ILE B 15 SITE 3 BC2 11 GLY B 16 GLY B 17 PRO B 63 SITE 1 BC3 11 HIS A 69 GOL A1102 HOH A2157 HOH A2158 SITE 2 BC3 11 PRO B 1 HIS B 69 ACT B1100 HOH B2168 SITE 3 BC3 11 HOH B2169 HOH B2172 HOH B2173 SITE 1 BC4 26 ARG A 8 ASP A 25 GLY A 27 ALA A 28 SITE 2 BC4 26 ASP A 29 ASP A 30 ILE A 47 GLY A 48 SITE 3 BC4 26 GLY A 49 ILE A 50 ILE A 84 HOH A2107 SITE 4 BC4 26 HOH A2112 HOH A2116 HOH A2117 ASP B 25 SITE 5 BC4 26 GLY B 27 ALA B 28 ASP B 29 VAL B 32 SITE 6 BC4 26 GLY B 48 GLY B 49 VAL B 82 ILE B 84 SITE 7 BC4 26 HOH B2098 HOH B2099 CRYST1 50.501 58.853 60.886 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019802 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016991 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016424 0.00000 MODEL 1